Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1 IPO registration
- 4.1 Promissory Note (March 2 2005)
- 4.2 Promissory Note (March 8 2005)
- 4.3 Termination Agreement
- 4.4 Common Stock Purchase Agreement
- 4.5 Registration Rights Agreement
- 4.6 Promissory Note (December 5 2005)
- 10.1 Crada Agreement with Usda
- 10.2 Amended Crada Agreement with Usda
- 10.5 Restated Finder Agreement
- 23.1 Consent of Sierchio Greco and Greco LLP
- 23.2 Consent of Moore Stephens Ellis Foster
- 23.3 Consent of Clancy and Co., PLLC
ADYX similar filings
Filing view
External links
EXHIBIT 23.2
MOORE STEPHENS
ELLIS FOSTER LTD.
CHARTERED ACCOUNTANTS
1650 West 1st Avenue
Vancouver, BC Canada V6J 1G1
Telephone: (604) 737-8117 Facsimile: (604) 714-5916
Website: www.ellisfoster.com
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our reports dated March 15, 2005 and March 15, 2004 in the Amendment No. 2 to the Registration Statement and the related Prospectus of HepaLife Technologies, Inc. for the registration of up to 10,711,598 shares of its common stock.
/s/Moore Stephens Ellis Foster Ltd.
Vancouver, British Columbia, Canada
Chartered Accountants
December 14, 2005